Benitec Biopharma (BNTC) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.76
-1.88
-0.99
-0.11

Details

Expected EPS
N/A
Actual EPS
-2.76
Surprise EPS
-2.76
Surprise Percent
+∞%

Description

Benitec Biopharma (BNTC) has reported earnings of -2.76 per share for Q3 2023.

0 Comments

Share your thoughts